Sanofi’s MS Candidate Tolebrutinib On Clinical Hold Following Liver Toxicities

But Studies Going Strong

 
• By Ayisha Sharma
  
liver
Liver Injury a concern for the US FDA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D